Search Within

Narek Shaverdian

Formats
  1. Meeting Abstract (50)
  2. Journal Article (37)
  3. Editorial (5)
  4. Research Letter (4)
  5. Review (3)
  6. Correspondence (1)
Groups
  1. Radiation Oncology, Department of (100)
  2. Department of Medicine (63)
  3. Solid Tumor Oncology Division (61)
  4. Thoracic Oncology (58)
  5. Weinberg Fellows (42)
  6. Graduate Medical Education (36)

More Groups

People
  1. Daniel Gomez (77)
  2. Andreas Rimner (67)
  3. Daphna Gelblum (66)
  4. Annemarie Shepherd (62)
  5. Abraham Wu (58)
  6. Charles Simone (42)

More People

Years
  1. 2025 (4)
  2. 2024 (17)
  3. 2023 (18)
  4. 2022 (16)
  5. 2021 (21)
  6. 2020 (16)

More Years

Publications
  1. International Journal of Radiation Oncology, Biology, Physics (35)
  2. Journal of Thoracic Oncology (14)
  3. Radiotherapy and Oncology (9)
  4. Advances in Radiation Oncology (6)
  5. Journal of Clinical Oncology (5)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. Elsevier Inc. (67)
  2. American Society of Clinical Oncology (7)
  3. American Medical Association (3)
  4. AME Publishing Company (2)
  5. American Association for Cancer Research (2)
  6. Oxford University Press (2)

More Publishers

Results (100)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Minimal residual disease (MRD) detection by ctDNA in relation to radiographic disease progression in patients with stage I-III non-small cell lung cancer (NSCLC) treated with definitive radiation therapy
    Meeting Abstract

    Lebow, E. S.; Murciano-Goroff, Y. R.; Jee, J.; Kalashnikova, E.; Feeney, J.; Sethi, H.; Aleshin, A.; Kris, M. G.; Chaft, J. E.; Rudin, C. M.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Final analysis of consolidative use of radiotherapy to block (CURB) oligoprogression trial - A randomized study of stereotactic body radiotherapy for oligoprogressive metastatic lung and breast cancers
    Meeting Abstract

    Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Eng, J.; Yeh, R.; Girshman, J.; Das, J.; Gelblum, D.; Xu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Circulating tumor DNA to identify genomic biomarkers of radiation sensitivity in locally advanced non-small cell lung cancer
    Meeting Abstract

    Lebow, E.; Li, B. T.; Sheverdian, N.; Eichholz, J.; Kratochvil, L. B.; Gelblum, D. Y.; Simone, C. B. 2nd; Shepherd, A. F.; Shin, J. Y.; Rimner, A.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Planned interim analysis of a phase II trial of concurrent durvalumab and radiation therapy for locally advanced lung cancer
    Meeting Abstract

    Rimner, A.; Fitzgerald, K.; Iqbal, A. N.; Shepherd, A. F.; Gomez, D. R.; Shin, J. Y.; Gelblum, D. Y.; Hajj, C.; Albrecht, F.; Kotecha, R. R.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Mutations in CREBBP are associated with local failure after lung stereotactic body radiation therapy
    Meeting Abstract

    Ng, V.; Rimner, A.; Sidiqi, B.; Lebow, E. S.; Shaverdian, N.; Gelblum, D. Y.; Shepherd, A. F.; Simone, C. B. 2nd; Gomez, D. R.; Wu, A. J.
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • iSABR: Safety and efficacy results from a phase II study of SABR in combination with durvalumab for early-stage medically inoperable NSCLC
    Meeting Abstract

    Lee, P.; Stube, A.; Felix, C.; Oseguera, D.; Romero, T.; Goldman, J.; Garon, E.; Lee, J. M.; Glaspy, J.; Lisberg, A. E.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Stereotactic body radiotherapy for sarcoma pulmonary metastases
    Meeting Abstract

    Lebow, E. S.; Lobaugh, S.; Zhang, Z.; Dickson, M.; Thornton, K.; Rosenbaum, E.; D'Angelo, S.; Nacev, B.; Shepherd, A. F.; Shaverdian, N.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Biomarkers associated with pulmonary exacerbations in a prospective, placebo-controlled, randomized trial of nintedanib for the treatment of radiation pneumonitis
    Meeting Abstract

    Moore, Z. R.; Huang, X.; Lobaugh, S.; Geyer, A.; Gelblum, D.; Shepherd, A. F.; Shaverdian, N.; Wu, A. J.; Chaft, J.; Zauderer, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • 40 Gray in 5 fractions for salvage re-irradiation of spine lesions previously treated with stereotactic body radiotherapy
    Meeting Abstract

    Moore, A.; Zhang, Z.; Schmitt, A.; Higginson, D. S.; Mueller, B. A.; Zinovoy, M.; Gelblum, D.; Yerramilli, D.; Xu, A. J.; Brennan, V. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Factors associated with outcomes in patients with metastatic NSCLC receiving osimertinib and consolidative radiation therapy
    Meeting Abstract

    Ma, J.; Yu, H.; Gelblum, D.; Kroen, E.; Shaverdian, N.; Tsai, C. J.; Yang, J. T.; Rimner, A.; Huang, J.; Gomez, D. R.
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save